Utah Medical Products UTMD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $10.85M-3.9% | $11.29M-2.9% | $11.62M-7.4% | $12.55M-3.1% | $12.96M-6.6% | ||
| $837K+1.3% | $826K+1.5% | $814K+0.7% | $808K+4.4% | $774K+6.0% | ||
| $411K+10.2% | $373K+11.7% | $334K+14.0% | $293K+13.1% | $259K+1.2% | ||
| -$589K+8.1% | -$641K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$90K+92.5% | -$1.2M-9.8% | -$1.09M-3.2% | -$1.05M-78.3% | -$591K-0.7% | ||
| —— | —— | —— | —— | -$86K-17.8% | ||
| —— | —— | —— | -$2.25M-33.0% | -$1.69M-12.6% | ||
| $120K+122% | $54K+58.8% | $34K+150% | -$68K-134% | -$29K-191% | ||
| -$918K-24,810,812,365% | -$0-100% | $2.49M+61.9% | $1.54M— | —— | ||
| $2.08M-2.2% | $2.13M+0.8% | $2.11M+1.0% | $2.09M+1.4% | $2.06M-0.2% | ||
| $59K+5.4% | $56K+3.7% | $54K+5.9% | $51K+4.1% | $49K-3.9% | ||
| —— | —— | -$263K+65.4% | -$760K-171% | -$280K-419% | ||
| $13.34M-9.2% | $14.69M+3.8% | $14.15M+0.2% | $14.13M+0.8% | $14.02M-5.5% | ||
| $317K-14.6% | $371K+36.9% | $271K-18.6% | $333K-15.1% | $392K+70.4% | ||
| $668K0.0% | $668K+15.8% | $577K-0.9% | $582K-17.1% | $702K-13.8% | ||
| -$317K+14.6% | -$371K-36.9% | -$271K+18.6% | -$333K+16.1% | -$397K-90.9% | ||
| $3.96M-0.7% | $3.98M-1.5% | $4.04M-1.6% | $4.11M-1.9% | $4.19M-1.7% | ||
| $5.26M-37.0% | $8.36M-40.6% | $14.07M-18.6% | $17.28M-14.4% | $20.2M+1.2% | ||
| -$9.22M+25.3% | -$12.34M+31.9% | -$18.11M+15.3% | -$21.39M+11.2% | -$24.09M-1.1% | ||
| —— | —— | —— | —— | —— | ||
| $4.08M+46.8% | $2.78M+166% | -$4.19M+40.6% | -$7.04M+32.8% | -$10.48M-6.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $3.99M-0.4% | $4M+6.0% | $3.78M-9.5% | $4.17M-8.8% | $4.58M-1.3% | ||
| $2.08M-2.2% | $2.13M+0.8% | $2.11M+1.0% | $2.09M+1.4% | $2.06M-0.2% | ||
| $837K+1.3% | $826K+1.5% | $814K+0.7% | $808K+4.4% | $774K+6.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | -$659K-12.8% | -$584K-14.7% | -$509K-17.3% | -$434K-20.9% | ||
| —— | $5K+151% | -$9.75K+60.2% | -$24.5K+37.6% | -$39.25K+27.3% | ||
| $120K+122% | $54K+58.8% | $34K+150% | -$68K-134% | -$29K-191% | ||
| $59K+5.4% | $56K+3.7% | $54K+5.9% | $51K+4.1% | $49K-3.9% | ||
| —— | —— | —— | —— | —— | ||
| $412K+10.2% | $374K+11.6% | $335K+14.3% | $293K+13.1% | $259K+1.2% | ||
| $15.79M-4.4% | $16.52M-0.3% | $16.57M0.0% | $16.57M+1.3% | $16.36M-2.4% | ||
| —— | $3.44M-41.2% | $5.85M— | —— | —— | ||
| $3.38-2.9% | $3.48-1.7% | $3.54-5.3% | $3.74-1.1% | $3.78-4.3% | ||
| $3.38-2.9% | $3.48-1.7% | $3.54-5.6% | $3.75-1.1% | $3.79-4.3% | ||
| —— | 41.9%+1.9% | 40%— | —— | —— | ||
| —— | $7.88M+0.1% | $7.87M+0.1% | $7.86M+0.1% | $7.85M+0.1% | ||
| $21.75M-1.2% | $22M-0.3% | $22.06M-0.9% | $22.26M-2.9% | $22.92M-5.1% | ||
| $13.43M-4.8% | $14.11M-49.3% | $27.81M-3.0% | $28.68M-1.3% | $29.05M-3.1% | ||
| $10.81M-5.2% | $11.4M-4.1% | $11.89M-5.8% | $12.62M-1.9% | $12.86M-5.4% | ||
| $37.53M-2.6% | $38.52M-0.3% | $38.63M-0.5% | $38.83M-1.1% | $39.27M-4.0% | ||
| —— | $20K+6.7% | $18.75K+7.1% | $17.5K+7.7% | $16.25K+8.3% | ||
| —— | $2.05M+1.9% | $2.01M+1.9% | $1.98M+1.9% | $1.94M+2.0% | ||
| —— | —— | —— | —— | —— | ||
| 0— | 0— | 0— | 0— | 0— | ||
| 12.9M-1.0% | 13M-2.0% | 13.3M-2.0% | 13.5M-2.1% | 13.8M-2.2% | ||
| 12.9M-1.0% | 13M-2.0% | 13.3M-2.0% | 13.5M-2.1% | 13.8M-2.2% | ||
| —— | —— | —— | —— | —— | ||
| $13.02M-9.1% | $14.32M+3.2% | $13.88M+0.6% | $13.8M+1.2% | $13.63M-6.7% | ||
| $13.02M-9.1% | $14.32M+3.2% | $13.88M+0.6% | $13.8M+1.2% | $13.63M-6.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Utah Medical Products generate?
- Utah Medical Products (UTMD) generated $13.3M in operating cash flow over the trailing twelve months.
- What is Utah Medical Products's free cash flow?
- After $317.0K of capital expenditures, Utah Medical Products's free cash flow was $13.0M over the trailing twelve months, down 4.5% year over year.
- Where does Utah Medical Products's cash flow data come from?
- Every line is extracted from Utah Medical Products's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
